glp-1 heart disease Can agonists treat cardiovascular diseases? GLP-1 Receptor Agonists in Heart

This may be due to the increased COX2 expression leading to lipid peroxidation (the main process of ferroptosis) and increased effects of substrates on the pathogenesis and prognosis of CRC

This streamlined model passes savings directly to patients

Additionally, behavioral therapy helps address underlying mental health issues and teaches healthy coping strategies

Well explore what science tells us so far, whats still unclear, and why these drugs may ultimately be a double-edged sword for brain health

doi: 10.3389/fcell.2025.1559300 Received 12 January 2025 Accepted 29 May 2025 Published 09 June 2025 Volume 13 - 2025 Edited by Ariane Zamoner, Federal University of Santa Catarina, Brazil Reviewed by Belm Sampaio-Marques, University of Minho, Portugal Heidar Heidari Khoei, Austrian Academy of Sciences (OeAW), Austria Updates Copyright 2025 Khodaei, Noori, Zare and Meshkin